AMP-activated protein kinase attenuates Wnt/β-catenin signaling in human osteoblastic Saos-2 cells

Molecular and Cellular Endocrinology

Volumn 339, Issue 1-2, 2011, Pages 114-119

  Takatani, Tomozumi ^a   Minagawa, Masanori ^a   Takatani, Rieko ^a   Kinoshita, Kaori ^a   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Catenin; AMPK; Metformin; Osteoblast; Wnt

Indexed keywords

BETA CATENIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; T CELL FACTOR PROTEIN; WNT PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BETA CATENIN; CELL LINE; CULTURE MEDIA, CONDITIONED; GENES, REPORTER; HUMANS; LITHIUM CHLORIDE; LUCIFERASES, FIREFLY; METFORMIN; MICE; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; T CELL TRANSCRIPTION FACTOR 1; TRANSCRIPTIONAL ACTIVATION; VIDARABINE; WNT PROTEINS;

EID: 79958035489     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.04.003     Document Type: Article

References (42)

1. Babij P., Zhao W., Small C., Kharode Y., Yaworsky P.J., Bouxsein M.L., Reddy P.S., Bodine P.V., Robinson J.A., Bhat B., Marzolf J., Moran R.A., Bex F. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 2003, 18:960-974.
2. Barnes B.R., Ryder J.W., Steiler T.L., Fryer L.G., Carling D., Zierath J.R. Isoform-specific regulation of 5′ AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction. Diabetes 2002, 51:2703-2708.
3. Chen Z., Heierhorst J., Mann R.J., Mitchelhill K.I., Michell B.J., Witters L.A., Lynch G.S., Kemp B.E., Stapleton D. Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. FEBS Lett. 1999, 460:343-348.
4. Cheung P.C., Salt I.P., Davies S.P., Hardie D.G., Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 2000, 346:659-669.
5. Cortizo A.M., Sedlinsky C., McCarthy A.D., Blanco A., Schurman L. Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur. J. Pharmacol. 2006, 536:38-46.
6. Davidson M.B., Peters A.L. An overview of metformin in the treatment of type 2 diabetes mellitus. Am. J. Med. 1997, 102:99-110.
7. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell. 2005, 8:739-750.
8. Eivers E., Demagny H., De Robertis E.M. Integration of BMP and Wnt signaling via vertebrate Smad1/5/8 and Drosophila Mad. Cytokine Growth Factor Rev. 2009, 20:357-365.
9. Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., Taketo M.M., Long F., McMahon A.P., Lang R.A., Karsenty G. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 2005, 8:751-764.
10. Hartmann C. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 2006, 16:151-158.
11. Holmen S.L., Giambernardi T.A., Zylstra C.R., Buckner-Berghuis B.D., Resau J.H., Hess J.F., Glatt V., Bouxsein M.L., Ai M., Warman M.L., Williams B.O. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J. Bone Miner. Res. 2004, 19:2033-2040.
12. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
13. Kanazawa I., Yamaguchi T., Yano S., Yamauchi M., Sugimoto T. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem. Biophys. Res. Commun. 2008, 375:414-419.
14. Kasai T., Bandow K., Suzuki H., Chiba N., Kakimoto K., Ohnishi T., Kawamoto S., Nagaoka E., Matsuguchi T. Osteoblast differentiation is functionally associated with decreased AMP kinase activity. J. Cell. Physiol. 2009, 221:740-749.
15. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H., Glass D.A., Hartmann C., Li L., Hwang T.H., Brayton C.F., Lang R.A., Karsenty G., Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 2002, 157:303-314.
16. Kefas B.A., Cai Y., Ling Z., Heimberg H., Hue L., Pipeleers D., Van de Casteele M. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J. Mol. Endocrinol. 2003, 30:151-161.
17. Kemp B.E., Stapleton D., Campbell D.J., Chen Z.P., Murthy S., Walter M., Gupta A., Adams J.J., Katsis F., van Denderen B., Jennings I.G., Iseli T., Michell B.J., Witters L.A. AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans. 2003, 31:162-168.
18. Kinjo M., Setoguchi S., Solomon D.H. Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample. J. Clin. Endocrinol. Metab. 2007, 92:4161-4164.
19. Kolligs F.T., Hu G., Dang C.V., Fearon E.R. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 1999, 19:5696-5706.
20. Labbé E., Letamendia A., Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8358-8363.
21. Lee M.H., Koria P., Qu J., Andreadis S.T. JNK phosphorylates beta-catenin and regulates adherens junctions. FASEB J. 2009, 23:3874-3883.
22. Lee Y.M., Uhm K.O., Lee E.S., Kwon J., Park S.H., Kim H.S. AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway. Biochem. Biophys. Res. Commun. 2008, 370:641-645.
23. Liu Y., Wan Q., Guan Q., Gao L., Zhao J. High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem. Biophys. Res. Commun. 2006, 339:701-707.
24. Macsai C.E., Foster B.K., Xian C.J. Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J. Cell. Physiol. 2008, 215:578-587.
25. Mitchelhill K.I., Stapleton D., Gao G., House C., Michell B., Katsis F., Witters L.A., Kemp B.E. Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem. 1994, 269:2361-2364.
26. Mulholland D.J., Dedhar S., Coetzee G.A., Nelson C.C. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?. Endocr. Rev. 2005, 26:898-915.
27. Piters E., Boudin E., Van Hul W. Wnt signaling: a win for bone. Arch. Biochem. Biophys. 2008, 473:112-116.
28. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. (Oxf) 2009, 196:65-80.
29. Sriwijitkamol A., Ivy J.L., Christ-Roberts C., DeFronzo R.A., Mandarino L.J., Musi N. LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E925-E932.
30. Stapleton D., Gao G., Michell B.J., Widmer J., Mitchelhill K., Teh T., House C.M., Witters L.A., Kemp B.E. Mammalian 5′-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J. Biol. Chem. 1994, 269:29343-29346.
31. Stapleton D., Mitchelhill K.I., Gao G., Widmer J., Michell B.J., Teh T., House C.M., Fernandez C.S., Cox T., Witters L.A., Kemp B.E. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 1996, 271:611-614.
32. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009, 89:1025-1078.
33. Steinberg G.R., Michell B.J., van Denderen B.J., Watt M.J., Carey A.L., Fam B.C., Andrikopoulos S., Proietto J., Görgün C.Z., Carling D., Hotamisligil G.S., Febbraio M.A., Kay T.W., Kemp B.E. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 2006, 4:465-474.
34. Strutt D. Frizzled signalling and cell polarisation in Drosophila and vertebrates. Development 2003, 130:4501-4513.
35. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1995, 333:550-554.
36. Veeman M.T., Slusarski D.C., Kaykas A., Louie S.H., Moon R.T. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 2003, 13:680-685.
37. Yamaguchi T., Kanazawa I., Yamamoto M., Kurioka S., Yamauchi M., Yano S., Sugimoto T. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone 2009, 45:174-179.
38. Yu X., McCorkle S., Wang M., Lee Y., Li J., Saha A.K., Unger R.H., Ruderman N.B. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 2004, 47:2012-2021.
39. Yun H., Kim H.S., Lee S., Kang I., Kim S.S., Choe W., Ha J. AMP kinase signaling determines whether c-Jun N-terminal kinase promotes survival or apoptosis during glucose deprivation. Carcinogenesis 2009, 30:529-537.
40. Zhang L., Li J., Young L.H., Caplan M.J. AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17272-17277.
41. Zhao J., Yue W., Zhu M.J., Sreejayan N., Du M. AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552. Biochem. Biophys. Res. Commun. 2010, 395:146-151.
42. Zheng B., Cantley L.C. Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:819-822.